Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration - Implications for increased neurofibroma formation during pregnancy

Todd D. Nebesio, Wenyu Ming, Shi Chen, Travis Clegg, Jin Yuan, Yanzhu Yang, Selina A. Estwick, Yan Li, Xiaohong Li, Cynthia M. Hingtgen, Feng-Chun Yang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Neurofibromas are the clinical hallmark of neurofibromatosis Type 1 (NF1), a genetic disorder caused by mutations of the NF1 tumor suppressor gene, which encodes neurofibromin that functions as a GTPase activating protein (GAP) for Ras. During pregnancy, up to 50% of existing neurofibromas enlarge and as many as 60% of new neurofibromas appear for the first time. Lysophosphatidic acid (LPA) is a prototypic lysophospholipid that modulates cell migration and survival of Schwann cells (SCs) and is made in increasing concentrations throughout pregnancy. We addressed the influence of LPA on the biochemical and cellular functions of SCs with a homozygous mutation of the murine homologue of the NF1 gene (Nf1-/-). LPA promoted F-actin polymerization and increased migration and survival of Nf1-/- SCs as compared to wild type (WT) SCs. Furthermore, LPA induced a higher level of Ras-GTP and Akt phosphorylation in Nf1-/- SCs as compared to WT cells. Pharmacologic inhibition or siRNA for the p85β regulatory subunit of Class I A PI3-K significantly reduced LPA-induced Schwann cell survival and migration. Introduction of NF1-GRD reconstitution was sufficient to normalize the LPA-mediated motility of Nf1-/- SCs. As LPA modulates excessive cell survival and motility of Nf1-/- SCs, which are the tumorigenic cells in NF1, targeting PI3-K may be a potential therapeutic approach in diminishing the development and progression of neurofibromas in pregnant women with NF1.

Original languageEnglish (US)
Pages (from-to)527-536
Number of pages10
JournalGLIA
Volume55
Issue number5
DOIs
StatePublished - Apr 1 2007
Externally publishedYes

Fingerprint

Neurofibromin 1
Neurofibroma
Schwann Cells
Neurofibromatosis 1
Pregnancy
Cell Movement
Cell Survival
Neurofibromatosis 1 Genes
ras GTPase-Activating Proteins
Lysophospholipids
Mutation
Inborn Genetic Diseases
lysophosphatidic acid
Guanosine Triphosphate
Tumor Suppressor Genes
Polymerization
Small Interfering RNA
Actins
Pregnant Women
Phosphorylation

Keywords

  • lpa
  • nf1
  • pi3-k
  • ras

ASJC Scopus subject areas

  • Immunology

Cite this

Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration - Implications for increased neurofibroma formation during pregnancy. / Nebesio, Todd D.; Ming, Wenyu; Chen, Shi; Clegg, Travis; Yuan, Jin; Yang, Yanzhu; Estwick, Selina A.; Li, Yan; Li, Xiaohong; Hingtgen, Cynthia M.; Yang, Feng-Chun.

In: GLIA, Vol. 55, No. 5, 01.04.2007, p. 527-536.

Research output: Contribution to journalArticle

Nebesio, Todd D. ; Ming, Wenyu ; Chen, Shi ; Clegg, Travis ; Yuan, Jin ; Yang, Yanzhu ; Estwick, Selina A. ; Li, Yan ; Li, Xiaohong ; Hingtgen, Cynthia M. ; Yang, Feng-Chun. / Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration - Implications for increased neurofibroma formation during pregnancy. In: GLIA. 2007 ; Vol. 55, No. 5. pp. 527-536.
@article{b6e1f96a0d8e46c3be3a1d55b2339ea1,
title = "Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration - Implications for increased neurofibroma formation during pregnancy",
abstract = "Neurofibromas are the clinical hallmark of neurofibromatosis Type 1 (NF1), a genetic disorder caused by mutations of the NF1 tumor suppressor gene, which encodes neurofibromin that functions as a GTPase activating protein (GAP) for Ras. During pregnancy, up to 50{\%} of existing neurofibromas enlarge and as many as 60{\%} of new neurofibromas appear for the first time. Lysophosphatidic acid (LPA) is a prototypic lysophospholipid that modulates cell migration and survival of Schwann cells (SCs) and is made in increasing concentrations throughout pregnancy. We addressed the influence of LPA on the biochemical and cellular functions of SCs with a homozygous mutation of the murine homologue of the NF1 gene (Nf1-/-). LPA promoted F-actin polymerization and increased migration and survival of Nf1-/- SCs as compared to wild type (WT) SCs. Furthermore, LPA induced a higher level of Ras-GTP and Akt phosphorylation in Nf1-/- SCs as compared to WT cells. Pharmacologic inhibition or siRNA for the p85β regulatory subunit of Class I A PI3-K significantly reduced LPA-induced Schwann cell survival and migration. Introduction of NF1-GRD reconstitution was sufficient to normalize the LPA-mediated motility of Nf1-/- SCs. As LPA modulates excessive cell survival and motility of Nf1-/- SCs, which are the tumorigenic cells in NF1, targeting PI3-K may be a potential therapeutic approach in diminishing the development and progression of neurofibromas in pregnant women with NF1.",
keywords = "lpa, nf1, pi3-k, ras",
author = "Nebesio, {Todd D.} and Wenyu Ming and Shi Chen and Travis Clegg and Jin Yuan and Yanzhu Yang and Estwick, {Selina A.} and Yan Li and Xiaohong Li and Hingtgen, {Cynthia M.} and Feng-Chun Yang",
year = "2007",
month = "4",
day = "1",
doi = "10.1002/glia.20482",
language = "English (US)",
volume = "55",
pages = "527--536",
journal = "GLIA",
issn = "0894-1491",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration - Implications for increased neurofibroma formation during pregnancy

AU - Nebesio, Todd D.

AU - Ming, Wenyu

AU - Chen, Shi

AU - Clegg, Travis

AU - Yuan, Jin

AU - Yang, Yanzhu

AU - Estwick, Selina A.

AU - Li, Yan

AU - Li, Xiaohong

AU - Hingtgen, Cynthia M.

AU - Yang, Feng-Chun

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Neurofibromas are the clinical hallmark of neurofibromatosis Type 1 (NF1), a genetic disorder caused by mutations of the NF1 tumor suppressor gene, which encodes neurofibromin that functions as a GTPase activating protein (GAP) for Ras. During pregnancy, up to 50% of existing neurofibromas enlarge and as many as 60% of new neurofibromas appear for the first time. Lysophosphatidic acid (LPA) is a prototypic lysophospholipid that modulates cell migration and survival of Schwann cells (SCs) and is made in increasing concentrations throughout pregnancy. We addressed the influence of LPA on the biochemical and cellular functions of SCs with a homozygous mutation of the murine homologue of the NF1 gene (Nf1-/-). LPA promoted F-actin polymerization and increased migration and survival of Nf1-/- SCs as compared to wild type (WT) SCs. Furthermore, LPA induced a higher level of Ras-GTP and Akt phosphorylation in Nf1-/- SCs as compared to WT cells. Pharmacologic inhibition or siRNA for the p85β regulatory subunit of Class I A PI3-K significantly reduced LPA-induced Schwann cell survival and migration. Introduction of NF1-GRD reconstitution was sufficient to normalize the LPA-mediated motility of Nf1-/- SCs. As LPA modulates excessive cell survival and motility of Nf1-/- SCs, which are the tumorigenic cells in NF1, targeting PI3-K may be a potential therapeutic approach in diminishing the development and progression of neurofibromas in pregnant women with NF1.

AB - Neurofibromas are the clinical hallmark of neurofibromatosis Type 1 (NF1), a genetic disorder caused by mutations of the NF1 tumor suppressor gene, which encodes neurofibromin that functions as a GTPase activating protein (GAP) for Ras. During pregnancy, up to 50% of existing neurofibromas enlarge and as many as 60% of new neurofibromas appear for the first time. Lysophosphatidic acid (LPA) is a prototypic lysophospholipid that modulates cell migration and survival of Schwann cells (SCs) and is made in increasing concentrations throughout pregnancy. We addressed the influence of LPA on the biochemical and cellular functions of SCs with a homozygous mutation of the murine homologue of the NF1 gene (Nf1-/-). LPA promoted F-actin polymerization and increased migration and survival of Nf1-/- SCs as compared to wild type (WT) SCs. Furthermore, LPA induced a higher level of Ras-GTP and Akt phosphorylation in Nf1-/- SCs as compared to WT cells. Pharmacologic inhibition or siRNA for the p85β regulatory subunit of Class I A PI3-K significantly reduced LPA-induced Schwann cell survival and migration. Introduction of NF1-GRD reconstitution was sufficient to normalize the LPA-mediated motility of Nf1-/- SCs. As LPA modulates excessive cell survival and motility of Nf1-/- SCs, which are the tumorigenic cells in NF1, targeting PI3-K may be a potential therapeutic approach in diminishing the development and progression of neurofibromas in pregnant women with NF1.

KW - lpa

KW - nf1

KW - pi3-k

KW - ras

UR - http://www.scopus.com/inward/record.url?scp=33847711059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847711059&partnerID=8YFLogxK

U2 - 10.1002/glia.20482

DO - 10.1002/glia.20482

M3 - Article

VL - 55

SP - 527

EP - 536

JO - GLIA

JF - GLIA

SN - 0894-1491

IS - 5

ER -